Innovation Through Pioneering Technology SM


Call us today 800-522-5052

For billing information:



Comprehensive Respiratory Panel
 

FilmArray® Respiratory

Panel 2 (RP2)




An estimated 55% of antibiotic prescriptions for acute respiratory tract infections are unnecessary, facilitating the development of antibiotic resistant infections.1 Each year in the US, 2 million people acquire serious bacterial infections that are resistant to one or more prescribed antibiotics, and at least 23,000 people die as a direct result of these antibiotic resistant infections.2

Enzo is pleased to announce the addition of the FilmArray Respiratory Panel 2 (RP2). The FilmArray RP2 tests nasopharyngeal swab (NPS) specimens for a comprehensive set of 21 respiratory pathogens commonly associated with respiratory infections. Quickly identifying pathogens facilitates appropriate treatment and patient management decisions.


 
Adults average 2-5 upper
respiratory tract infections each
year while children average
7-10 upper respiratory tract
infections a year.3
ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt

FilmArray RP2

21 Targets in One Test

The FilmArray Respiratory Panel 2 tests for a comprehensive panel of 21 respiratory viral and bacterial pathogens. With its innovative PCR technology, the RP2 panel identifies the most common viral and bacterial pathogens that cause respiratory infections with an overall sensitivity and specificity of 95% and 99% respectively.

Impact on Clinical Workflow

  • Distinguishes specifically between viral and bacterial infections quickly and accurately
  • Allows for informed diagnosis and therapy
  • Facilitates appropriate utilization of antibiotics



   Viral Targets     Bacterial Targets
  • Adenovirus
  • Coronavirus HKU1
  • Coronavirus NL63
  • Coronavirus 229E
  • Coronavirus OC43
  • Human Metapneumovirus
  • Human Rhinovirus/Enterovirus
  • Influenza A
  • Influenza A/H1
  • Influenza A/H3
  • Influenza A/H1-2009
  • Influenza B
  • Parainfluenza Virus 1
  • Parainfluenza Virus 2
  • Parainfluenza Virus 3
  • Parainfluenza Virus 4
  • Respiratory Syncytial Virus
    (RSV)
  • Bordetella pertussis
  • Bordetella parapertussis
  • Chlamydia pneumoniae
  • Mycoplasma pneumoniae


Advantages to ordering the FilmArray RP2:

  • Better Results – Compared to traditional or targeted methods, a syndromic approach increases the probability of identifying a pathogen in patients with symptoms of an infectious disease and it increases capability of detection of co-infections.
  • Accurate Organism Identification – The FilmArray System’s PCR technology for detection of bacteria and viruses offers increased sensitivity and specificity over traditional methods, particularly for viruses and difficult-to-culture organisms.
  • Specimen Requirements – NPS in transport medium. The PCR format minimizes sample requirements increasing efficiency. A single specimen can be tested for multiple infectious agents simultaneously.


For Additional Information on Respiratory Infections:

Infectious Disease Society of America. Lower and Upper Respiratory Guidelines. http://www.idsociety.org/Organ_System/#Lower/Upper Respiratory.

CDC Guidelines for preventing Health-Care Associated Pneumonia, 2003.
  
Test Name: Respiratory Panel

Test Code: 6940

Methodology: PCR

Specimen Req: Nasopharyngeal Swab


REFERENCES

1. CDC. Antibiotic Resistance Threats in the United States, 2013. http://www.cdc.gov/drugresistance/threat-report-2013/.

2. FilmArray Respiratory Panel [instruction booklet]. Salt Lake City, UT: BioFire Diagnostics; 2012: 3

3. Johnston S, Holgate S. Epidemiology of viral respiratory infections. In: Myint S, Taylor-Robinson D, eds. Viral and other infections of the human respiratory tract. London: Chapman & Hall, 1996: 1–38.